Media stories about IMS Health Holdings (NYSE:IMS) have been trending somewhat positive on Tuesday, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. IMS Health Holdings earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news articles about the information technology services provider an impact score of 46.488773127361 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

Shares of IMS Health Holdings (NYSE IMS) traded up 3.26% during trading on Tuesday, reaching $31.34. The company had a trading volume of 4,031,328 shares. The stock has a 50 day moving average of $31.34 and a 200 day moving average of $30.95. IMS Health Holdings has a 52-week low of $23.71 and a 52-week high of $31.34.

TRADEMARK VIOLATION NOTICE: “IMS Health Holdings (IMS) Given Daily News Sentiment Score of 0.16” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/29/ims-health-holdings-ims-given-daily-news-sentiment-score-of-0-16.html.

IMS Health Holdings Company Profile

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Insider Buying and Selling by Quarter for IMS Health Holdings (NYSE:IMS)

Receive News & Stock Ratings for IMS Health Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc and related stocks with our FREE daily email newsletter.